Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 13Terminated 5Withdrawn 2Unknown 2Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Polycythemia Vera 1Leukemia, Myeloid, Acute 1

Interventions

pembrolizumab 562Specimen Handling 490Carboplatin 451Magnetic Resonance Spectroscopy 444Cyclophosphamide 418Cisplatin 406Radiotherapy 353Gemcitabine 314Bevacizumab 313Paclitaxel 298Biopsy 290Drug Therapy 283Blood Specimen Collection 248Capecitabine 245Oxaliplatin 241fludarabine 240Nivolumab 234venetoclax 221Injections 213Docetaxel 211Fluorouracil 205Dexamethasone 187Radiosurgery 182Rituximab 159Standard of Care 158Pemetrexed 156Surgical Procedures, Operative 148durvalumab 145atezolizumab 145Leucovorin 139

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Interferons × Clear all
NCT04116502 2026-04-28

MITHRIDATE

University of Birmingham

Phase 3 Recruiting
586 enrolled
Myeloid

Polycythemia Vera

NCT06802718 2025-01-31

Interferon-alpha As Maintenance Therapy for Favorable-risk Acute Myeloid Leukemia

Peking University People's Hospital

Phase 3 Recruiting
96 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡